Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-019121
Filing Date
2013-04-01
Accepted
2013-04-01 16:05:45
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM10-K v337050_10k.htm 10-K 808236
2 EXHIBIT 10.4 v337050_ex10-4.htm EX-10.4 21054
3 EXHIBIT 21.1 v337050_ex21-1.htm EX-21.1 2758
4 EXHIBIT 31.1 v337050_ex31-1.htm EX-31.1 7716
5 EXHIBIT 31.2 v337050_ex31-2.htm EX-31.2 7469
6 EXHIBIT 32.1 v337050_ex32-1.htm EX-32.1 3832
  Complete submission text file 0001144204-13-019121.txt   5679970

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT xtls-20121231.xml EX-101.INS 578404
8 XBRL TAXONOMY EXTENSION SCHEMA xtls-20121231.xsd EX-101.SCH 56631
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtls-20121231_cal.xml EX-101.CAL 69847
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtls-20121231_def.xml EX-101.DEF 277055
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtls-20121231_lab.xml EX-101.LAB 489801
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtls-20121231_pre.xml EX-101.PRE 354769
Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2600 NEW YORK NY 10020 201-934-2000
Xstelos Holdings, Inc. (Filer) CIK: 0001540145 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-54646 | Film No.: 13731142
SIC: 2834 Pharmaceutical Preparations